Efficient Mining for Structurally Diverse Fusicoccane-Type Diterpenoids as Novel Antithrombotic Agents and Their Divergent Mechanisms on Platelet Inhibition
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c02817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Alan Bao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Scien…. Hauptthemen laut MEDLINE: Diterpenes, Fibrinolytic Agents, Platelet Aggregation Inhibitors, Blood Platelets. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Through genome mining, we discovered a 5/8/5 fusicoccane-type diterpenoid gene cluster (named Thm ) from the biocontrol fungus Trichoderma harzianum, representing the first report of such a cluster in the genus Trichoderma . Heterologous expression of Thm in Aspergillus oryzae NSAR1 led to the isolation of 33 fusicoccane-type diterpenoids (including 30 new compounds 1 – 30 ). Structurally, compounds 1 – 14 were tetracyclic diterpenoids, with 1 and 2 being a class of rare fusicoccane-alkaloid hybrids. Mechanistic profiling revealed that compound 6 acts as a selective GPVI pathway antagonist, potently inhibiting Syk and PLCγ2 phosphorylation and subsequent platelet activation. In contrast, compound 31 exerts its antiplatelet effect via a distinct ROCK1-dependent pathway, suppressing cytoskeletal reorganization by reducing myosin light chain (MLC) phosphorylation and key regulator expression. Critically, both compounds demonstrate a groundbreaking therapeutic dissociation, providing robust protection against arterial and venous thrombosis without impairing normal hemostasis, thereby presenting a promising strategy for safe antithrombotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Institute of Pharmaceutical Process, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
ORCID-Profile: Ying Ye, Yonghui Zhang, Hucheng Zhu
Förderung
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Bao, A., Gong, X., Lin, S., Gao, C., Wang, H., Wang, D., Sun, W., Chen, C., Li, Q., Ye, Y., Sun, W., Zhang, Y., & Zhu, H. (2026). Efficient Mining for Structurally Diverse Fusicoccane-Type Diterpenoids as Novel Antithrombotic Agents and Their Divergent Mechanisms on Platelet Inhibition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02817
Vancouver
Bao A, Gong X, Lin S, Gao C, Wang H, Wang D, et al. Efficient Mining for Structurally Diverse Fusicoccane-Type Diterpenoids as Novel Antithrombotic Agents and Their Divergent Mechanisms on Platelet Inhibition. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02817
BibTeX
@article{Bao2026,
author = {Bao, Alan and Gong, Xue and Lin, Shuang and Gao, Chi and Wang, Hao and Wang, Dongxiao and Sun, Wanghaoran and Chen, Chunmei and Li, Qin and Ye, Ying and Sun, Weiguang and Zhang, Yonghui and Zhu, Hucheng},
title = {Efficient Mining for Structurally Diverse Fusicoccane-Type Diterpenoids as Novel Antithrombotic Agents and Their Divergent Mechanisms on Platelet Inhibition},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c02817}
}
EUVIMED